Low-dose antithymocyte globulin, post-transplant cyclophosphamide and sirolimus as graft-versus-host disease prophylaxis in unrelated donor transplants

被引：0
|
作者：
Greco, R. [1 ]
Crucitti, L. [2 ]
Vago, L. [1 ,3 ]
Cieri, N. [2 ,4 ]
Giglio, F. [1 ]
Stanghellini, M. T. Lupo [1 ]
Morelli, M. [1 ]
Barbanti, M. C. [1 ]
Piemontese, S. [1 ]
Perini, T. [1 ]
Sala, E. [1 ]
Pavesi, F. [1 ]
Messina, C. [1 ]
Milani, R. [5 ]
Marcatti, M. [1 ]
Marktel, S. [1 ]
Carrabba, M. [1 ]
Bernardi, M. [1 ]
Corti, C. [1 ]
Assanelli, A. [1 ]
Bonini, C. [4 ]
Ciceri, F. [1 ]
Peccatori, J. [1 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Unit Hematol & Bone Marrow Transplantat, Milan, Italy
[2] Univ Milan, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Unit Immunogenet Leukemia Genom & Immunobiol, Milan, Italy
[4] IRCCS San Raffaele Sci Inst, Expt Hematol Unit, Milan, Italy
[5] IRCCS San Raffaele Sci Inst, Immunohematol & Transfus Med Unit, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P608
引用
收藏
页码：S438 / S439
页数：2
相关论文
共 50 条
  • [21] Antithymocyte globulin for graft-versus-host disease prophylaxis: mistakenly maligned
    Segovia, Javier
    van Besien, Koen
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 841 - 842
  • [22] Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
    Law, Arjun Datt
    Salas, Maria Queralt
    Lam, Wilson
    Michelis, Fotios V.
    Thyagu, Santhosh
    Kim, Dennis
    Lipton, Jeffrey Howard
    Kumar, Rajat
    Messner, Hans
    Viswabandya, Auro
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (11) : 2259 - 2264
  • [23] Treatment of acute graft-versus-host disease with low-dose, alternate-day antithymocyte globulin
    Graziani, F
    Van Lint, MT
    Dominietto, A
    Raiola, AM
    Di Grazia, C
    Lamparelli, T
    Gualandi, F
    Bregante, S
    Fiorone, M
    Bruno, B
    Bacigalupo, A
    [J]. HAEMATOLOGICA, 2002, 87 (09) : 973 - 978
  • [24] Dual T lymphocyte suppression with antithymocyte globulin and post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplant for acute leukemias and myelodysplastic syndrome
    Kim, D. H.
    Park, Y.
    Shin, D-Y.
    Koh, Y.
    Byun, J. M.
    Hong, J.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S1517 - S1518
  • [25] Graft-versus-host disease prophylaxis with antithymocyte globulin: Which is more important, dose or timing?
    Sormani, M. P.
    Ibatici, A.
    Dominietto, A.
    van Lint, M. T.
    Gualandi, F.
    Lamparelli, T.
    Occhini, D.
    Di Grazia, C.
    Bregante, S.
    Raiola, A. M.
    Frassoni, F.
    Bacigalupo, A.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S25 - S25
  • [26] Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation
    Uday Deotare
    Eshetu G. Atenafu
    David Loach
    Fotios V. Michelis
    Dennis (Dong-Hwan) Kim
    Santhosh Thyagu
    Jeffrey H. Lipton
    Hans A. Messner
    Auro Viswabandya
    [J]. Bone Marrow Transplantation, 2018, 53 : 361 - 365
  • [27] Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation
    Al Malki, Monzr M.
    Bo-Subait, Stephanie
    Logan, Brent
    Olson, Janelle
    Leckrone, Erin
    Wu, Juan
    Stefanski, Heather E.
    Auletta, Jeffery J.
    Spellman, Stephen R.
    Malmberg, Craig
    Shaffer, Brian C.
    Modi, Dipenkumar
    Khimani, Farhad
    Gooptu, Mahasweta
    Hamadani, Mehdi
    Broglie, Larisa
    Shaw, Bronwen E.
    Devine, Steven Michael
    Jimenez, Antonio Martin Jimenez
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation
    Deotare, Uday
    Atenafu, Eshetu G.
    Loach, David
    Michelis, Fotios V.
    Kim, Dennis
    Thyagu, Santhosh
    Lipton, Jeffrey H.
    Messner, Hans A.
    Viswabandya, Auro
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 (03) : 361 - 365
  • [29] Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in HLAMatched and Haploidentical Donor Transplants for Patients with Hodgkin disease: A Comparative Study of the LWP EBMT
    Montoro, Juan
    Boumendil, Ariane
    Finel, Herve
    Bramanti, Stefania
    Luca, Castagna, Sr.
    Blaise, Didier
    Dominietto, Alida
    Aleksandr, Kulagin, Sr.
    Yakoub-Agha, Ibrahim
    Tbakhi, Abdelghani
    Solano, Carlos
    Giebel, Sebastian
    Gulbas, Zafer
    Caballero, Dolores
    Perez-Simon, Jose A.
    Diez Martin, Jose Luis
    Corradini, Paolo
    Koc, Yener
    Socie, Gerard
    Arat, Mutlu
    Jurado, Manuel
    Bermudez, Arancha
    Labussiere-Wallet, Helene
    Villalba, Marta
    Ciceri, Fabio
    Rovira, Montserrat
    Nagler, Arnon
    Sureda Balari, Anna Maria
    Glass, Bertram
    [J]. BLOOD, 2023, 142
  • [30] Impact of graft versus host disease prophylaxis on outcomes of unmanipulated haploidentical stem cell transplantation: post-transplant cyclophosphamide versus antithymocyte globulin based regimen
    Ruggeri, A.
    Sun, Y.
    Labopin, M.
    Lorentino, F.
    Bacigalupo, A.
    Arcese, W.
    Santarone, S.
    Gulbas, Z.
    Blaise, D.
    Irrera, G.
    Ghavamzadeh, A.
    Malard, F.
    Bruno, B.
    Diez-Martin, J. L.
    Koc, Y.
    Ciceri, F.
    Mohty, M.
    Nagler, A.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S27 - S27
12345